
Galapagos NV GLPG
€ 28.56
1.26%
Geschäftsbericht 2024
hinzugefügt 14.02.2026
Galapagos NV P/CF 2011-2026 | GLPG
P/CF Jährlich Galapagos NV
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | -8.78 | -15.9 | 0.004 | -37.5 | -39.8 | 259 | -14.4 | -7.88 | -95.4 | 11.4 | - |
Alle Zahlen in EUR-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 259 | -95.4 | 5.04 |
P/CF anderer Aktien in der Pharmaeinzelhändler
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-0.654 | - | 2.43 % | $ 254 M | ||
|
Amarin Corporation plc
AMRN
|
64 | $ 14.81 | -0.34 % | $ 6.04 B | ||
|
Acer Therapeutics
ACER
|
-0.401 | - | 2.71 % | $ 14 M | ||
|
Acasti Pharma
ACST
|
-2.73 | - | 4.01 % | $ 150 M | ||
|
I-Mab
IMAB
|
-0.266 | - | - | $ 866 M | ||
|
Adverum Biotechnologies
ADVM
|
-0.826 | - | - | $ 86.2 M | ||
|
Legend Biotech Corporation
LEGN
|
-56.2 | $ 17.8 | -1.44 % | $ 18.7 B | ||
|
Anavex Life Sciences Corp.
AVXL
|
-7.45 | $ 3.93 | 0.26 % | $ 335 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-0.64 | - | - | $ 26.5 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
11.6 | - | - | $ 40.3 B | ||
|
Adagene
ADAG
|
-2.96 | $ 3.24 | 13.85 % | $ 182 M | ||
|
Biophytis SA
BPTS
|
-23.1 | - | -13.47 % | $ 169 M | ||
|
Akouos
AKUS
|
-2.7 | - | 0.23 % | $ 488 M | ||
|
Aptorum Group Limited
APM
|
-3.44 | $ 0.79 | -7.27 % | $ 4.31 M | ||
|
AlloVir
ALVR
|
-0.723 | - | 4.14 % | $ 49.1 M | ||
|
Midatech Pharma plc
MTP
|
-13.2 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.88 | - | -1.52 % | $ 24.7 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-0.0776 | - | -11.43 % | $ 502 K | ||
|
Alterity Therapeutics Limited
ATHE
|
-94.9 | $ 3.48 | -0.98 % | $ 8.37 B | ||
|
Applied Molecular Transport
AMTI
|
-0.236 | - | - | $ 10.1 M | ||
|
ARCA biopharma
ABIO
|
-8.36 | - | 1052.0 % | $ 415 M | ||
|
Biogen
BIIB
|
13.3 | $ 195.63 | 0.06 % | $ 28.7 B | ||
|
Acorda Therapeutics
ACOR
|
-1.2 | - | -24.86 % | $ 820 K | ||
|
Aptose Biosciences
APTO
|
-0.0645 | - | -45.71 % | $ 1.2 M | ||
|
Akero Therapeutics
AKRO
|
-14.1 | - | - | $ 3.67 B | ||
|
Athira Pharma
ATHA
|
-0.166 | - | - | $ 269 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-4.6 | - | - | $ 1.01 B | ||
|
Albireo Pharma
ALBO
|
-5 | - | -0.23 % | $ 916 M | ||
|
Институт стволовых клеток человека
ISKJ
|
-89 | - | - | - | ||
|
Allena Pharmaceuticals
ALNA
|
-2.48 | - | 3.16 % | $ 1.9 M | ||
|
Ascendis Pharma A/S
ASND
|
-17.6 | $ 216.28 | -0.83 % | $ 5 B | ||
|
Bristol-Myers Squibb Company
BMY
|
8.64 | $ 60.51 | 1.12 % | $ 123 B | ||
|
Aptinyx
APTX
|
-0.159 | - | -39.0 % | $ 4.57 M | ||
|
Aravive
ARAV
|
-0.928 | - | -13.39 % | $ 1.45 M | ||
|
Arena Pharmaceuticals
ARNA
|
-12.5 | - | -6.81 % | $ 3.04 B | ||
|
BioNTech SE
BNTX
|
70.7 | $ 106.24 | 0.45 % | $ 27.2 B | ||
|
Aridis Pharmaceuticals
ARDS
|
-0.142 | - | 17.91 % | $ 11.1 M | ||
|
Aeterna Zentaris
AEZS
|
-4.82 | - | 5.93 % | $ 314 M | ||
|
Brickell Biotech
BBI
|
-2.62 | - | -5.38 % | $ 6.06 M | ||
|
AgeX Therapeutics
AGE
|
-0.0018 | - | -10.17 % | $ 12.2 K | ||
|
Athersys
ATHX
|
-5.78 | - | 3.77 % | $ 22.4 M | ||
|
Avenue Therapeutics
ATXI
|
-0.0603 | - | -52.27 % | $ 4.45 M | ||
|
BeiGene, Ltd.
BGNE
|
-1.8 K | - | 0.49 % | $ 251 B | ||
|
Autolus Therapeutics plc
AUTL
|
-2.05 | $ 1.41 | 1.81 % | $ 360 M | ||
|
Burford Capital Limited
BUR
|
11.6 | $ 9.33 | 0.32 % | $ 1.51 B | ||
|
Amneal Pharmaceuticals
AMRX
|
6.19 | $ 14.8 | 1.13 % | $ 4.57 B | ||
|
AIkido Pharma
AIKI
|
-1.3 | - | 1.93 % | $ 17.4 M | ||
|
AVROBIO
AVRO
|
-0.891 | - | 1083.1 % | $ 745 M | ||
|
CureVac N.V.
CVAC
|
-4.82 | - | - | $ 867 M | ||
|
Alpine Immune Sciences
ALPN
|
-6.14 | - | - | $ 2.17 B |